Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05886582Phase 2Completed
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
Substance-Related Disorders
PrincipalinvestigatorStart date: 2023-09-11
NCT05179772Phase 2Withdrawn
Olanzapine in OUD Patients
Opioid Use Disorder
PrincipalinvestigatorStart date: 2022-07-28

Research Network

Collaboration Network

9 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Virginia Commonwealth University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Fiellin, MD

Yale University

Related
7 trials

Shared therapeutic areas:

Opioid Use DisorderSubstance-Related Disorders

Worked with same sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)National Institute on Drug Abuse (NIDA)+2 more
Similarity Score20%

Gerard Moeller, MD

Virgina Commonwealth University

Related
1 trials

Shared therapeutic areas:

Opioid Use Disorder

Worked with same sponsors:

University of Pennsylvania
Collaborated on 1 trial
Similarity Score14%

Tanya Ramey, PHD

National Institute on Drug Abuse (NIDA)

Related
1 trials

Shared therapeutic areas:

Substance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score14%

Kyle Kampman, MD

University of Pennsylvania

Related
4 trials

Shared therapeutic areas:

Opioid Use Disorder

Worked with same sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)National Institute on Drug Abuse (NIDA)+1 more
Collaborated on 1 trial
Similarity Score14%

James M Bjork, PhD

Virginia Commonwealth University

Related
1 trials

Shared therapeutic areas:

Substance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score14%

Heather Hadjistavropoulos, PhD

University of Regina

Related
15 trials

Shared therapeutic areas:

Alcohol Use Disorder
Similarity Score10%

Bernard Le Foll, MD, PhD

Centre for Addiction and Mental Health

Related
13 trials

Shared therapeutic areas:

Alcohol Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Jeffrey L Schnipper, MD, MPH

Brigham and Women's Hospital

Related
8 trials

Shared therapeutic areas:

Opioid Use Disorder
Similarity Score10%

Man Ping Wang, PhD

The University of Hong Kong

Related
17 trials

Shared therapeutic areas:

Alcohol Use Disorder
Similarity Score10%

Walter Ling, M.D.

Friends Research Institute, Inc.

Related
28 trials

Shared therapeutic areas:

Substance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05886582Phase 2PrincipalInvestigator

Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder

Substance-Related Disorders
Completed
NCT05179772Phase 2PrincipalInvestigator

Olanzapine in OUD Patients

Opioid Use Disorder
Withdrawn
NCT02900352Phase 3PrincipalInvestigator

Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action

Alcohol Use Disorder
Completed

All 3 trials loaded